Wealth Quarterback’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$11K Buy
89
+1
+1% +$116 0.01% 445
2021
Q2
$11K Buy
+88
New +$9.65K 0.01% 455
2020
Q1
Sell
-1,129
Closed -$14.1K 983
2019
Q4
$14.1K Buy
+1,129
New +$106K 0.01% 445

Other funds holding AZN

Wealth Quarterback's AZN Position: Q3 2021 in Review

Wealth Quarterback increased its AstraZeneca (AZN) stake by 1.1% in Q3 2021, buying an estimated $116 and bringing the position to 89 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #445.

Wealth Quarterback first reported a position in AZN in Q4 2019 and has held it in 3 quarters since. The position peaked at $14.1K in Q4 2019. 908 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

  • Wealth Quarterback held 89 shares of AstraZeneca worth $11K as of Q3 2021.
  • Wealth Quarterback bought 1 AstraZeneca share in Q3 2021, an estimated $116.
  • AstraZeneca made up 0.01% of Wealth Quarterback's portfolio in Q3 2021, its #445 holding.
  • Wealth Quarterback first reported a position in AstraZeneca in Q4 2019 and has held it in 3 quarters since.
  • Wealth Quarterback's AstraZeneca position peaked at $14.1K in Q4 2019.
  • 908 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.